While there are no data about PD-L1+ lymphocyte distribution impact on prognosis in NSCLC, the research in ovarian carcinoma revealed that neither PD-L1+ lymphocytes in the tumour stroma nor PD-L1+ lymphocytes in tumour islets had a significant association with prognostic variables [17]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.